Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sethi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sethi, S.
The Proceedings of the American Thoracic Society 1:109-114 (2004)
© 2004 The American Thoracic Society

Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease

Phenomenon or Epiphenomenon?

Sanjay Sethi

Department of Medicine, University of Buffalo SUNY, and VA WNY Healthcare System, Buffalo, New York

Correspondence and requests for reprints should be addressed to Sanjay Sethi, M.D., VA WNY Healthcare System, Medical Research 151, 3495 Bailey Avenue, Buffalo, NY 14215. E-mail: ssethi{at}buffalo.edu

Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of approximately half of the exacerbations in COPD. Acquisition of new strains of bacterial pathogens in patients with COPD is associated with a substantial increase in risk of exacerbation. Bacterial pathogens are isolated in significant concentrations from bronchoscopic samples obtained during acute exacerbation. Neutrophilic airway inflammation is associated with isolation of bacterial pathogens from sputum. A specific immune response to the infecting strains of bacterial pathogens isolated from sputum during exacerbations has been demonstrated. Future work should strive to understand better the host–pathogen interaction that leads to an exacerbation and to develop novel therapeutic and preventive measures.

Key Words: chronic obstructive pulmonary disease • exacerbation • bacteria • surface antigen • infection




This article has been cited by other articles:


Home page
ThoraxHome page
B G G Oliver, S Lim, P Wark, V Laza-Stanca, N King, J L Black, J K Burgess, M Roth, and S L Johnston
Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages
Thorax, June 1, 2008; 63(6): 519 - 525.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
F. J. Martinez
Pathogen-directed Therapy in Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, December 1, 2007; 4(8): 647 - 658.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
R. McGhan, T. Radcliff, R. Fish, E. R. Sutherland, C. Welsh, and B. Make
Predictors of Rehospitalization and Death After a Severe Exacerbation of COPD
Chest, December 1, 2007; 132(6): 1748 - 1755.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Phua, E. S. C. Koay, D. Zhang, L. K. Tai, X. L. Boo, K. C. Lim, and T. K. Lim
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
Eur. Respir. J., October 1, 2006; 28(4): 695 - 702.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
U. S. Sajjan, Y. Jia, D. C. Newcomb, J. K. Bentley, N. W. Lukacs, J. J. LiPuma, and M. B. Hershenson
H. influenzae potentiates airway epithelial cell responses to rhinovirus by increasing ICAM-1 and TLR3 expression
FASEB J, October 1, 2006; 20(12): 2121 - 2123.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S. S. Hurd, Y. Fukuchi, C. K. W. Lai, P. X. Ran, F. W. S. Ko, S. M. Liu, et al.
Increasing COPD awareness.
Eur. Respir. J., April 1, 2006; 27(4): 833 - 852.
[Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
E. R. Keith, R. G. Podmore, T. P. Anderson, and D. R. Murdoch
Characteristics of Streptococcus pseudopneumoniae Isolated from Purulent Sputum Samples.
J. Clin. Microbiol., March 1, 2006; 44(3): 923 - 927.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. P. Schleimer
Innate Immune Responses and Chronic Obstructive Pulmonary Disease: "Terminator" or "Terminator 2"?
Proceedings of the ATS, November 1, 2005; 2(4): 342 - 346.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
C. Pilette, S. R. Durham, J.-P. Vaerman, and Y. Sibille
Mucosal Immunity in Asthma and Chronic Obstructive Pulmonary Disease: A Role for Immunoglobulin A?
Proceedings of the ATS, April 1, 2004; 1(2): 125 - 135.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma
Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Thoracic Society.